Cite
HARVARD Citation
Reich, K. et al. (n.d.). THU0439 52-Week Efficacy and Safety of Apremilast and Switch from Etanercept in Patients with Moderate To Severe Psoriasis: Results from The Liberate Study. Annals of the rheumatic diseases. p. 349. [Online].